Bolt Biotherapeutics (BOLT)
NASDAQ:BOLT
Holding BOLT?
Track your performance easily

Bolt Biotherapeutics (BOLT) Financial Statements

204 Followers

Bolt Biotherapeutics Financial Overview

Bolt Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-1.741; its P/E ratio is -0.37; Bolt Biotherapeutics is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 1.27M$ 5.27M$ 2.09M$ 2.53M$ 1.43M
Gross Profit$ 1.27M$ 5.27M$ 2.09M$ 2.53M$ 1.43M
EBIT$ -21.20M$ -10.81M$ -19.77M$ -18.18M$ -18.06M
EBITDA$ -18.92M$ -10.61M$ -19.30M$ -17.72M$ -16.02M
Net Income Common Stockholders$ -21.20M$ -10.81M$ -17.90M$ -16.26M$ -18.06M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 73.70M$ 91.35M$ 102.19M$ 119.72M$ 125.87M
Total Assets$ 124.18M$ 142.89M$ 159.78M$ 175.35M$ 190.70M
Total Debt$ 18.89M$ 19.57M$ 20.22M$ 20.86M$ 21.47M
Net Debt$ -54.81M$ -71.78M$ -81.97M$ -98.87M$ -104.39M
Total Liabilities$ 38.32M$ 38.73M$ 47.04M$ 47.10M$ 48.56M
Stockholders Equity$ 85.86M$ 104.16M$ 112.74M$ 128.26M$ 142.13M
Cash Flow-
Free Cash Flow$ -16.14M$ -16.75M$ -14.27M$ -16.91M$ -15.14M
Operating Cash Flow$ -16.14M$ -16.75M$ -14.27M$ -16.75M$ -15.11M
Investing Cash Flow$ 18.00M$ 10.20M$ 15.81M$ 12.66M$ 13.58M
Financing Cash Flow$ 79.00K-$ 106.00K-$ 147.00K
Currency in USD

Bolt Biotherapeutics Earnings and Revenue History

Bolt Biotherapeutics Debt to Assets

Bolt Biotherapeutics Cash Flow

Bolt Biotherapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis